Custom Search


Login
MY ACCOUNT
support_button
Not a customer? Click Here
Video
ADVERTISEMENT
Today's Health Headlines
WASHINGTON (Reuters) - A congressional vote on a Republican healthcare plan may not come for weeks as leaders in the House of Representatives and the Senate continue negotiations over possible proposals, the White House said on Monday.

(Reuters) - Large drugmakers with piles of cash are on the hunt for promising medicines being developed by small companies to treat NASH, a progressive fatty liver disease poised to become the leading cause of liver transplants by 2020.

(Reuters Health) - Children in America’s poorest communities have three times the risk of dying from child abuse before age 5 as children in the wealthiest neighborhoods, a new study finds.

(Reuters) - Sanofi SA on Monday sued Mylan NV, accusing the pharmaceutical company of engaging in illegal conduct to squelch competition to its EpiPen allergy treatment, which has been at the center of a public debate over drug prices.

Diet and gut bacteria linked with blood clots
Mon, 24 Apr 2017 16:46:59 -0400
(Reuters Health) - Consuming too much choline, a nutrient sold in over-the-counter dietary supplements, can boost the risk for blood clots, researchers warn.

(Reuters Health) - Death of a sibling in childhood is associated with a greater risk of early death in the surviving brother or sister, researchers say.

PARIS (Reuters) - Iran has reported an outbreak of the highly contagious H5N1 bird flu virus in backyard ducks in the northern part of the country, the World Organisation for Animal Health (OIE) said on Monday, citing a report from the Iranian agriculture ministry.

(Reuters) - Eli Lilly and Co said the combination of its experimental breast cancer drug and a commonly used treatment met the main goal of a late-stage study in an interim analysis, setting the stage for a regulatory submission later this year.

China to ramp up crack-down on 'gutter oil'
Mon, 24 Apr 2017 08:45:43 -0400
BEIJING (Reuters) - China will intensify a crack down on the use of recycled "gutter oil", strengthening controls on oil origins and monitoring processing, according to a document released by the State Council on Monday.

NEW YORK (Reuters) - Shares of Eli Lilly & Co have staged a dramatic rebound following massive disappointment for its experimental Alzheimer's medicine late last year, outperforming rivals as investors warm to the drugmaker's profit outlook.

ADVERTISEMENT